Publication
Article
Results of an exclusive Urology Times survey point to urologists preferring intravesical chemotherapy for treating BCG-unresponsive NMIBC.
Click the image or this link to access the survey results
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.